| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 03/22/2007 | WO2006009699A3 Targeting damaged lung tissue |
| 03/22/2007 | US20070066893 Method |
| 03/22/2007 | US20070066535 Novel amino acid sequences are within the carboxy termini of fibrinogen; useful for cell culture and cell separation |
| 03/22/2007 | US20070066523 Chemokine analogs for the treatment of human diseases |
| 03/22/2007 | US20070065520 Mri contrast medium composition for oral administration |
| 03/22/2007 | US20070065365 Abuse-resistant transdermal system |
| 03/22/2007 | US20070065364 Tamper resistant dosage form comprising co-extruded, sequestered adverse agent particles and process of making same |
| 03/22/2007 | US20070065363 Quantifying hemodynamic response to drug therapy using implantable sensor |
| 03/22/2007 | CA2820201A1 Identification of tumor-associated antigens for diagnosis and therapy |
| 03/22/2007 | CA2621953A1 Biomarkers associated with age-related macular degeneration |
| 03/21/2007 | EP1763576A2 Ex-vivo application of solid microparticulate therapeutic agents |
| 03/21/2007 | EP1763371A2 Novel imaging agents comprising caspase-3 inhibitors |
| 03/21/2007 | EP1487343A4 Biospecific contrast agents |
| 03/21/2007 | EP0685994B1 Multipurpose reagent system for rapid lysis of whole blood samples |
| 03/21/2007 | CN1933851A Use of anti-alpha5beta1 antibodies to inhibit cancer cell proliferation |
| 03/21/2007 | CN1932513A Receiver plate with multiple cross-sections |
| 03/21/2007 | CN1305873C [18F] Fluorin marked pyridine compound and method for preparing the same and uses as dopamine D4 receptor developer |
| 03/20/2007 | US7193125 Trangenic rodent for use as model in evaluation of xenobiotics |
| 03/20/2007 | US7192770 Screening for a test agent that increases or induces a component of the p21 signal transduction pathway, thereby reducing the appearance or formation of wrinkles; used in fragrance or sunscreen |
| 03/20/2007 | US7192719 Antibodies specific for papillary fibroblasts as markers for skin quality |
| 03/20/2007 | CA2211100C Diagnostic imaging contrast agents with extended blood retention |
| 03/20/2007 | CA2142280C Metal-mediated cross-coupling with ring-metalated porphyrins |
| 03/15/2007 | WO2007030802A2 Targeted contrast agents and methods for targeting contrast agents |
| 03/15/2007 | WO2007030531A2 Reagents for testing and molecular imaging of liver cancer |
| 03/15/2007 | WO2007030083A2 N-(1-pyrene)maleimide, iaans and 5- (bromomethyl) fluorescein for covalent binding to md-2 and effect on the immune response |
| 03/15/2007 | WO2007028984A1 Apparatus and method for sonoporation |
| 03/15/2007 | WO2007028981A1 Apparatus and method for sonoporation |
| 03/15/2007 | WO2007028639A1 Method for the synthesis of pentapendant enantiomer-pure chelators and process for therapeutically active bio-conjugates preparation by a covalent binding of thereof |
| 03/15/2007 | WO2007028599A2 A fluorescent photoprobe for the imaging of endothelin receptors |
| 03/15/2007 | WO2007000349A3 Optical imaging of rheumatoid arthritis |
| 03/15/2007 | WO2006133903A3 Method, dye and medicament for staining the internal limiting memebrane, the vitreous and/or the capsule of an eye |
| 03/15/2007 | WO2006119994A3 Method for producing albumin conjugates comprising an x-ray contrast medium as the active substance |
| 03/15/2007 | WO2006119968A3 Compositions and methods using microspheres and non-ionic contrast agents |
| 03/15/2007 | WO2006114286A9 Production of albumin-fluorescein conjugates for use in intraoperative diagnosis |
| 03/15/2007 | WO2006107638A3 Non-degradable low swelling, water soluble radiopaque hydrogels |
| 03/15/2007 | WO2006106558A3 Use of nothobranchius furzeri as a model system for the characterisation of genes that control ageing |
| 03/15/2007 | WO2006054903A3 Method of cardiac imaging with the use of hyperpolarized 13 c-pyruvate |
| 03/15/2007 | WO2005069872A3 High throughput pharmaceutical screening using drosophila |
| 03/15/2007 | US20070061908 Transgenic animal for screening therapeutic agents for brain tumors |
| 03/15/2007 | US20070059316 Singlet oxygen photosensitizers activated by target binding enhancing the selectivity of targeted pdt agents |
| 03/15/2007 | US20070059248 Oxygen delivery agents and uses for the same |
| 03/15/2007 | US20070059247 Deposit contrast agents and related methods thereof |
| 03/15/2007 | US20070059246 Use of bile acid derivatives conjugated with metal ion chelated complexes for the diagnostic assessment of microvascular permeability |
| 03/15/2007 | US20070059245 Protein cages for the delivery of medical imaging and therapeutic agents |
| 03/15/2007 | US20070059244 Optical imaging of rheumatoid arthritis |
| 03/15/2007 | US20070059243 Method of treating or inhibiting the development of brain inflammation and sepsis |
| 03/15/2007 | US20070059242 Methods to identify therapeutic agents |
| 03/15/2007 | DE102005042086A1 Creating medical investigation picture of liver of a patient for investigating- and/or treatment of liver, comprises injecting water soluble iodine containing solution into the liver and creating a three dimensional image of the liver |
| 03/15/2007 | CA2621763A1 Targeted contrast agents and methods for targeting contrast agents |
| 03/15/2007 | CA2619879A1 A fluorescent photoprobe for the imaging of endothelin receptors |
| 03/14/2007 | EP1467706B1 Dermal application system for aminolevulinic acid-derivatives |
| 03/14/2007 | EP1337276B1 Artery smooth muscle- and vein smooth muscle-specific proteins and uses therefor |
| 03/14/2007 | EP1098979B1 Antibody with improved producibility |
| 03/14/2007 | CN1929869A Phospholipid analogs as diagnostic and therapeutic agents for numerous cancers |
| 03/14/2007 | CN1929868A Lyposome-containing x ray-imaging agent and method for producing the same |
| 03/14/2007 | CN1929849A Liquid composition for bulging mucous membrane for use in endoscopic surgery comprising a chitosan derivative containing carbohydrate chains |
| 03/14/2007 | CN1928115A Method for demonstrating efficacy of a topically applied active ingredient |
| 03/14/2007 | CN1927385A NK 3 receptor in vivo assay |
| 03/14/2007 | CN1927137A Pre-transplant accommodated organs resistant to anti-donor immunity |
| 03/14/2007 | CN1303999C Injectable galenic formulation for use in diagnosis or photodynamic therapy and method for preparing same |
| 03/14/2007 | CN1303985C Compositions comprising microparticles of water-insoluble substances and method for preparing same |
| 03/13/2007 | US7191109 medical equipment used for evaluation of drugs, by administering labeled substances, measuring radiation and generating images for regions of interest |
| 03/13/2007 | US7189505 Methods of assessing HIV integrase inhibitor therapy |
| 03/13/2007 | US7189417 Aqueous dispersion of amine-terminated silica particles having a narrowly controlled size range capable of coupling with an agent for diagnostic imaging, drug delivery or gene therapy |
| 03/13/2007 | US7189397 Screening fir cytotoxic end points; cancerous disease modifying antibodies |
| 03/13/2007 | US7189383 Compounds with halogen for diagnosis with ethers or sulfides for cancer |
| 03/13/2007 | US7189198 Magnetically guidable carriers and methods for the targeted magnetic delivery of substances in the body |
| 03/13/2007 | CA2171111C Inhibition of urinary calculi growth |
| 03/08/2007 | WO2007028163A1 Biocompatible fluorescent imaging agents |
| 03/08/2007 | WO2007028141A2 Imaging agents and methods of using same for detecting multidrug resistance in cancer |
| 03/08/2007 | WO2007028037A1 Biocompatible n, n-disubstituted sulfonamide-containing fluorescent dye labels |
| 03/08/2007 | WO2007028032A2 Intraoperative determination of nerve location |
| 03/08/2007 | WO2007027584A2 Deposit contrast agents and related methods thereof |
| 03/08/2007 | WO2007026960A1 Use of mocs3 gene for therapeutic or diagnostic purposes |
| 03/08/2007 | WO2007026533A1 Soluble tablet containing nanosilicon particles and process for production thereof |
| 03/08/2007 | WO2007026173A1 Transgenic animal model for identifying modulators of protein kinase |
| 03/08/2007 | WO2007025768A1 Optically fluorescent nanoparticles |
| 03/08/2007 | WO2006068653A3 Nanoparticles with inorganic core and methods of using them |
| 03/08/2007 | WO2006037625A3 Non-invasive method for assessing gastric motility |
| 03/08/2007 | WO2006004429A3 Imaging agents comprising a non- peptidic vector linked to a fluorophore via a polyethylene glycol linker |
| 03/08/2007 | US20070056049 p53 and VEGF regulate tumor growth of NOS2 expressing cancer cells |
| 03/08/2007 | US20070055113 Method and apparatus for homeopathic provings and diagnosis |
| 03/08/2007 | US20070053840 A tetrapyrollic photosensitizer compound with one pendant CH2CH2CON(CH2CON(CH2COOH)2)2 or N(CH2COOH)2 group, being a chlorin, bacteriochlorin, porphyrin, pyropheophorbide, purpurinimide, or bacteriopurpurinimide; water soluble photosensitizing and imaging compounds; hyperproliferative tissue |
| 03/08/2007 | US20070053839 Directing cells to target tissues organs |
| 03/08/2007 | US20070053837 Radiopharmaceuticals for cancer diagnosis and treatment |
| 03/08/2007 | US20070053836 Cytotoxicity mediation of cells evidencing surface expression of CD44 |
| 03/08/2007 | DE112005000868T5 Nicht-GMO-Metallminosäure-Chelate und Zusammensetzungen, die Nicht-GMO-Metallaminosäure-Chelate enthalten Contain non-GMO Metallminosäure chelates and compositions non-GMO metal amino acid chelates |
| 03/08/2007 | CA2621303A1 Biomarkers and methods for determining sensitivity to vascular endothelial growth factor receptor-2 modulators |
| 03/08/2007 | CA2621137A1 Biocompatible n,n-disubstituted sulfonamide-containing fluorescent dye labels |
| 03/08/2007 | CA2619676A1 Optically fluorescent nanoparticles |
| 03/07/2007 | EP1760467A1 Optically fluorescent nanoparticles |
| 03/07/2007 | EP1759634A2 Use of 1,1,1,2-Tetrafluoroethane for lung function evaluation |
| 03/07/2007 | EP1759199A2 Insulin-independent, bone morphogenetic protein (bmp)-mediated uptake of blood glucose by peripheral cells and tissues |
| 03/07/2007 | EP1759197A1 Method of determining performance of an antiperspirant composition |
| 03/07/2007 | EP1758616A1 Use in the medical, diagnostic and phlebological field of a mixture of sterile and physiologically acceptable gases |
| 03/07/2007 | EP1560603B1 Method for measuring pancreatic metabolism |
| 03/07/2007 | EP1100549B1 A novel excipient for the lyophilization of aqueous suspensions of microparticles |
| 03/07/2007 | CN1925878A Contrast agents for myocardial perfusion imaging |
| 03/07/2007 | CN1925877A Methylamine risks and treatment with N-derivatives of hyperactivity, depression and alcoholism |
| 03/07/2007 | CN1925876A Conjugates of angiotensin peptidic analogues and chelating agents for diagnosis and therapy |